Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients
2018 · BMC Cancer · 36 citations
https://doi.org/10.1186/s12885-018-4020-7
M
Marianna Alunni‐Fabbroni
LMU Klinikum(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
109
Papers
2.4K
Citations
23
h-index
39
i10-index
Marianna Alunni‐Fabbroni is an academic researcher from LMU Klinikum. The author has contributed to research in topics: Cancer Cells and Metastasis & Hepatocellular Carcinoma Treatment and Prognosis & Cancer Genomics and Diagnostics. The author has an h-index of 23, co-authored 93 publications.
ORCID: 0000-0002-9710-1662Papers by this author
worksComparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients
2016 · Oncology · 19 citations
https://doi.org/10.1159/000442986
Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer – Results of the German SUCCESS-A- trial
2016 · BMC Cancer · 17 citations
https://doi.org/10.1186/s12885-016-2454-3
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer
2017 · Clinical Breast Cancer · 10 citations
https://doi.org/10.1016/j.clbc.2016.11.008
CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC
2024 · Translational Oncology · 3 citations
https://doi.org/10.1016/j.tranon.2024.101919
Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity
2025 · JHEP Reports · 2 citations
https://doi.org/10.1016/j.jhepr.2025.101513
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat